• 1
    Sievert DM, Ricks P, Edwards JR et al. Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009–2010. Infect Control Hosp Epidemiol 2013; 34: 114.
  • 2
    Gupta N, Limbago BM, Patel JB, Kallen AJ. Carbapenem-resistant Enterobacteriaceae: epidemiology and prevention. Clin Infect Dis 2011; 53: 6067.
  • 3
    Nordmann P, Naas T, Poirel L. Global spread of carbapenemase-producing Enterobacteriaceae. Emerg Infect Dis 2011; 17: 17911798.
  • 4
    Ofner-Agostini M, Varia M, Johnston L et al. Infection control and antimicrobial restriction practices for antimicrobial-resistant organisms in Canadian tertiary care hospitals. Am J Infect Control 2007; 35: 563568.
  • 5
    Siegel JD, Rhinehart E, Jackson M, Chiarello L. Management of multidrug-resistant organisms in health care settings, 2006. Am J Infect Control 2007; 35(Suppl 2): S165S193.
  • 6
    Centers for Disease Control and Prevention (CDC). Guidance for control of infections with carbapenem-resistant or carbapenemase-producing Enterobacteriaceae in acute care facilities. MMWR Morb Mortal Wkly Rep 2009; 58: 256260.
  • 7
    Magiorakos AP, Srinivasan A, Carey RB et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 2012; 18: 268281.
  • 8
    Stone SP, Cooper BS, Kibbler CC et al. The ORION statement: guidelines for transparent reporting of outbreak reports and intervention studies of nosocomial infection. Lancet Infect Dis 2007; 7: 282288.
  • 9
    Russo TA, Johnson JR. Proposal for a new inclusive designation for extraintestinal pathogenic isolates of Escherichia coli: EXPEC. J Infect Dis 2000; 181: 17531754.
  • 10
    Scott E, Bloomfield SF. The survival and transfer of microbial contamination via cloths, hands and utensils. J Appl Bacteriol 1990; 68: 271278.
  • 11
    Karisik E, Ellington MJ, Pike R, Warren RE, Livermore DM, Woodford N. Molecular characterization of plasmids encoding CTX-M-15 β-lactamases from Escherichia coli strains in the United Kingdom. J Antimicrob Chemother 2006; 58: 665668.
  • 12
    Johnson JR, Menard M, Johnston B, Kuskowski MA, Nichol K, Zhanel GG. Epidemic clonal groups of Escherichia coli as a cause of antimicrobial-resistant urinary tract infections in Canada, 2002 to 2004. Antimicrob Agents Chemother 2009; 53: 27332739.
  • 13
    Johnson JR, Johnston B, Clabots C, Kuskowski MA, Castanheira M. Escherichia coli sequence type ST131 as the major cause of serious multidrug-resistant E. coli infections in the United States. Clin Infect Dis 2010; 51: 286294.
  • 14
    Nicolas-Chanoine MH, Blanco J, Leflon-Guibout V et al. Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15. J Antimicrob Chemother 2008; 61: 273281.
  • 15
    Blanco J, Mora A, Mamani R et al. National survey of Escherichia coli causing extraintestinal infections reveals the spread of drug-resistant clonal groups O25B:H4-B2-ST131, O15:H1-D-ST393 and CGA-D-ST69 with high virulence gene content in Spain. J Antimicrob Chemother 2011; 66: 20112021.
  • 16
    Ben-Ami R, Schwaber MJ, Navon-Venezia S et al. Influx of extended-spectrum β-lactamase-producing Enterobacteriaceae into the hospital. Clin Infect Dis 2006; 42: 925934.
  • 17
    Rodriguez-Bano J, Navarro MD, Romero L et al. Clinical and molecular epidemiology of extended-spectrum β-lactamase-producing Escherichia coli as a cause of nosocomial infection or colonization: implications for control. Clin Infect Dis 2006; 42: 3745.
  • 18
    McMullan R, Loughrey AC, McCalmont M, Rooney PJ. Clinico-epidemiological features of infections caused by CTX-M type extended spectrum β lactamase-producing Escherichia coli in hospitalised patients. J Infect 2007; 54: 4652.
  • 19
    Dubois V, De Barbeyrac B, Rogues AM et al. CTX-M-producing Escherichia coli in a maternity ward: a likely community importation and evidence of mother-to-neonate transmission. J Antimicrob Chemother 2010; 65: 13681371.
  • 20
    Hammerum AM, Heuer OE. Human health hazards from antimicrobial-resistant Escherichia coli of animal origin. Clin Infect Dis 2009; 48: 916921.
  • 21
    Kenny JF, Medearis DN, Klein SW, Drachman RH, Gibson LE. An outbreak of urinary tract infections and septicemia due to Escherichia coli in male infants. J Pediatr 1966; 68: 530541.
  • 22
    Sweet AY, Wolinsky E. An outbreak of urinary tract and other infections due to E. coli. Pediatrics 1964; 33: 865871.
  • 23
    Tullus K, Horlin K, Svenson SB, Kallenius G. Epidemic outbreaks of acute pyelonephritis caused by nosocomial spread of p fimbriated Escherichia coli in children. J Infect Dis 1984; 150: 728736.
  • 24
    Paterson DL, Singh N, Rihs JD, Squier C, Rihs BL, Muder RR. Control of an outbreak of infection due to extended-spectrum β-lactamase-producing Escherichia coli in a liver transplantation unit. Clin Infect Dis 2001; 33: 126128.
  • 25
    Nogueras M, Marinsalta N, Roussell M, Notario R. Importance of hand germ contamination in health-care workers as possible carriers of nosocomial infections. Rev Inst Med Trop Sao Paulo 2001; 43: 149152.
  • 26
    Harris AD, Kotetishvili M, Shurland S et al. How important is patient-to-patient transmission in extended-spectrum β-lactamase Escherichia coli acquisition. Am J Infect Control 2007; 35: 97101.
  • 27
    Adler A, Gniadkowski M, Baraniak A et al. Transmission dynamics of ESBL-producing Escherichia coli clones in rehabilitation wards at a tertiary care centre. Clin Microbiol Infect 2012; 18: E497E505.
  • 28
    Tschudin-Sutter S, Frei R, Dangel M, Stranden A, Widmer AF. Rate of transmission of extended-spectrum β-lactamase-producing Enterobacteriaceae without contact isolation. Clin Infect Dis 2012; 55: 15051511.
  • 29
    Hilty M, Betsch BY, Bogli-Stuber K et al. Transmission dynamics of extended-spectrum β-lactamase-producing Enterobacteriaceae in the tertiary care hospital and the household setting. Clin Infect Dis 2012; 55: 967975.
  • 30
    Podschun R, Ullmann U. Klebsiella spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenicity factors. Clin Microbiol Rev 1998; 11: 589603.
  • 31
    Rodriguez-Bano J, Pascual A. Clinical significance of extended-spectrum β-lactamases. Expert Rev Anti Infect Ther 2008; 6: 671683.
  • 32
    Harris AD, Perencevich EN, Johnson JK et al. Patient-to-patient transmission is important in extended-spectrum β-lactamase-producing Klebsiella pneumoniae acquisition. Clin Infect Dis 2007; 45: 13471350.
  • 33
    Casewell M, Phillips I. Hands as route of transmission for Klebsiella species. Br Med J 1977; 2: 13151317.
  • 34
    Riser E, Noone P, Howard FM. Epidemiological study of Klebsiella infection in the special care baby unit of a London hospital. J Clin Pathol 1980; 33: 400407.
  • 35
    Mayhall CG, Lamb VA, Bitar CM et al. Nosocomial Klebsiella infection in a neonatal unit: identification of risk factors for gastrointestinal colonization. Infect Control 1980; 1: 239246.
  • 36
    Coovadia YM, Johnson AP, Bhana RH, Hutchinson GR, George RC, Hafferjee IE. Multiresistant Klebsiella pneumoniae in a neonatal nursery: the importance of maintenance of infection control policies and procedures in the prevention of outbreaks. J Hosp Infect 1992; 22: 197205.
  • 37
    Gorman LJ, Sanai L, Notman AW, Grant IS, Masterton RG. Cross infection in an intensive care unit by Klebsiella pneumoniae from ventilator condensate. J Hosp Infect 1993; 23: 2734.
  • 38
    Su LH, Leu HS, Chiu YP et al. Molecular investigation of two clusters of hospital-acquired bacteraemia caused by multi-resistant Klebsiella pneumoniae using pulsed-field gel electrophoresis and in frequent restriction site PCR. Infection control group. J Hosp Infect 2000; 46: 110117.
  • 39
    Gastmeier P, Groneberg K, Weist K, Ruden H. A cluster of nosocomial Klebsiella pneumoniae bloodstream infections in a neonatal intensive care department: identification of transmission and intervention. Am J Infect Control 2003; 31: 424430.
  • 40
    Gupta A, Della-Latta P, Todd B et al. Outbreak of extended-spectrum β-lactamase-producing Klebsiella pneumoniae in a neonatal intensive care unit linked to artificial nails. Infect Control Hosp Epidemiol 2004; 25: 210215.
  • 41
    Waters V, Larson E, Wu F et al. Molecular epidemiology of Gram-negative bacilli from infected neonates and health care workers’ hands in neonatal intensive care units. Clin Infect Dis 2004; 38: 16821687.
  • 42
    Cassettari VC, Silveira IR, Balsamo AC, Franco F. Outbreak of extended-spectrum β-lactamase-producing Klebsiella pneumoniae in an intermediate-risk neonatal unit linked to onychomycosis in a healthcare worker. J Pediatr (Rio J) 2006; 82: 313316.
  • 43
    Krishna BV, Patil AB, Chandrasekhar MR. Extended spectrum β lactamase producing Klebsiella pneumoniae in neonatal intensive care unit. Indian J Pediatr 2007; 74: 627630.
  • 44
    Iregbu KC, Anwaal U. Extended spectrum β-lactamase-producing Klebsiella pneumoniae septicaemia outbreak in the neonatal intensive care unit of a tertiary hospital in Nigeria. Afr J Med Med Sci 2007; 36: 225228.
  • 45
    Dashti AA, Jadaon MM, Gomaa HH, Noronha B, Udo EE. Transmission of a Klebsiella pneumoniae clone harbouring genes for CTX-M-15-like and SHV-112 enzymes in a neonatal intensive care unit of a Kuwaiti hospital. J Med Microbiol 2010; 59: 687692.
  • 46
    Macrae MB, Shannon KP, Rayner DM, Kaiser AM, Hoffman PN, French GL. A simultaneous outbreak on a neonatal unit of two strains of multiply antibiotic resistant Klebsiella pneumoniae controllable only by ward closure. J Hosp Infect 2001; 49: 183192.
  • 47
    Bagattini M, Crivaro V, Di Popolo A et al. Molecular epidemiology of extended-spectrum β-lactamase-producing Klebsiella pneumoniae in a neonatal intensive care unit. J Antimicrob Chemother 2006; 57: 979982.
  • 48
    Calbo E, Freixas N, Xercavins M et al. Foodborne nosocomial outbreak of SHV-1 and CTX-M-15-producing Klebsiella pneumoniae: epidemiology and control. Clin Infect Dis 2011; 52: 743749.
  • 49
    Lowe C, Willey B, O'Shaughnessy A et al. Outbreak of extended-spectrum β-lactamase-producing Klebsiella oxytoca infections associated with contaminated handwashing sinks. Emerg Infect Dis 2012; 18: 12421247.
  • 50
    Weist K, Pollege K, Schulz I, Ruden H, Gastmeier P. How many nosocomial infections are associated with cross-transmission? A prospective cohort study in a surgical intensive care unit. Infect Control Hosp Epidemiol 2002; 23: 127132.
  • 51
    Vonberg RP, Gastmeier P. Hospital-acquired infections related to contaminated substances. J Hosp Infect 2007; 65: 1523.
  • 52
    Stamm WE, Kolff CA, Dones EM et al. A nursery outbreak caused by Serratia marcescens – scalp-vein needles as a portal of entry. J Pediatr 1976; 89: 9699.
  • 53
    Schaberg DR, Alford RH, Anderson R, Farmer JJ 3rd, Melly MA, Schaffner W. An outbreak of nosocomial infection due to multiply resistant Serratia marcescens: evidence of interhospital spread. J Infect Dis 1976; 134: 181188.
  • 54
    Anagnostakis D, Fitsialos J, Koutsia C, Messaritakis J, Matsaniotis N. A nursery outbreak of Serratia marcescens infection. Evidence of a single source of contamination. Am J Dis Child 1981; 135: 413414.
  • 55
    Rutala WA, Kennedy VA, Loflin HB, Sarubbi FA Jr. Serratia marcescens nosocomial infections of the urinary tract associated with urine measuring containers and urinometers. Am J Med 1981; 70: 659663.
  • 56
    Christensen GD, Korones SB, Reed L, Bulley R, McLaughlin B, Bisno AL. Epidemic Serratia marcescens in a neonatal intensive care unit: importance of the gastrointestinal tract as a reservoir. Infect Control 1982; 3: 127133.
  • 57
    Wilhelmi I, Bernaldo de Quiros JC, Romero-Vivas J, Duarte J, Rojo E, Bouza E. Epidemic outbreak of Serratia marcescens infection in a cardiac surgery unit. J Clin Microbiol 1987; 25: 12981300.
  • 58
    van Ogtrop ML, van Zoeren-Grobben D, Verbakel-Salomons EM, van Boven CP. Serratia marcescens infections in neonatal departments: description of an outbreak and review of the literature. J Hosp Infect 1997; 36: 95103.
  • 59
    Villari P, Crispino M, Salvadori A, Scarcella A. Molecular epidemiology of an outbreak of Serratia marcescens in a neonatal intensive care unit. Infect Control Hosp Epidemiol 2001; 22: 630634.
  • 60
    Milisavljevic V, Wu F, Larson E et al. Molecular epidemiology of Serratia marcescens outbreaks in two neonatal intensive care units. Infect Control Hosp Epidemiol 2004; 25: 719721.
  • 61
    de Vries JJ, Baas WH, van der Ploeg K, Heesink A, Degener JE, Arends JP. Outbreak of Serratia marcescens colonization and infection traced to a healthcare worker with long-term carriage on the hands. Infect Control Hosp Epidemiol 2006; 27: 11531158.
  • 62
    Ivanova D, Markovska R, Hadjieva N, Schneider I, Mitov I, Bauernfeind A. Extended-spectrum β-lactamase-producing Serratia marcescens outbreak in a Bulgarian hospital. J Hosp Infect 2008; 70: 6065.
  • 63
    Bayramoglu G, Buruk K, Dinc U, Mutlu M, Yilmaz G, Aslan Y. Investigation of an outbreak of Serratia marcescens in a neonatal intensive care unit. J Microbiol Immunol Infect 2011; 44: 111115.
  • 64
    Harbarth S, Sudre P, Dharan S, Cadenas M, Pittet D. Outbreak of Enterobacter cloacae related to understaffing, overcrowding, and poor hygiene practices. Infect Control Hosp Epidemiol 1999; 20: 598603.
  • 65
    Yu WL, Cheng HS, Lin HC, Peng CT, Tsai CH. Outbreak investigation of nosocomial Enterobacter cloacae bacteraemia in a neonatal intensive care unit. Scand J Infect Dis 2000; 32: 293298.
  • 66
    Robins-Browne RM, Rowe B, Ramsaroop R et al. A hospital outbreak of multiresistant Salmonella typhimurium belonging to phage type 193. J Infect Dis 1983; 147: 210216.
  • 67
    Lamb VA, Mayhall CG, Spadora AC, Markowitz SM, Farmer JJ 3rd, Dalton HP. Outbreak of Salmonella typhimurium gastroenteritis due to an imported strain resistant to ampicillin, chloramphenicol, and trimethoprim-sulfamethoxazole in a nursery. J Clin Microbiol 1984; 20: 10761079.
  • 68
    Revathi G, Shannon KP, Stapleton PD, Jain BK, French GL. An outbreak of extended-spectrum, β-lactamase-producing Salmonella senftenberg in a burns ward. J Hosp Infect 1998; 40: 295302.
  • 69
    Bouallegue-Godet O, Ben Salem Y, Fabre L et al. Nosocomial outbreak caused by Salmonella enterica serotype livingstone producing CTX-M-27 extended-spectrum β-lactamase in a neonatal unit in Sousse, Tunisia. J Clin Microbiol 2005; 43: 10371044.
  • 70
    Pena C, Suarez C, Tubau F et al. Nosocomial spread of Pseudomonas aeruginosa producing the metallo-β-lactamase VIM-2 in a Spanish hospital: clinical and epidemiological implications. Clin Microbiol Infect 2007; 13: 10261029.
  • 71
    Crivaro V, Di Popolo A, Caprio A et al. Pseudomonas aeruginosa in a neonatal intensive care unit: molecular epidemiology and infection control measures. BMC Infect Dis 2009; 9: 70.
  • 72
    Widmer AF, Wenzel RP, Trilla A, Bale MJ, Jones RN, Doebbeling BN. Outbreak of Pseudomonas aeruginosa infections in a surgical intensive care unit: probable transmission via hands of a health care worker. Clin Infect Dis 1993; 16: 372376.
  • 73
    Foca M, Jakob K, Whittier S et al. Endemic Pseudomonas aeruginosa infection in a neonatal intensive care unit. N Engl J Med 2000; 343: 695700.
  • 74
    Bertrand X, Bailly P, Blasco G, Balvay P, Boillot A, Talon D. Large outbreak in a surgical intensive care unit of colonization or infection with Pseudomonas aeruginosa that overexpressed an active efflux pump. Clin Infect Dis 2000; 31: E9E14.
  • 75
    Rogues AM, Boulestreau H, Lasheras A et al. Contribution of tap water to patient colonisation with Pseudomonas aeruginosa in a medical intensive care unit. J Hosp Infect 2007; 67: 7278.
  • 76
    Saiman L. Infection prevention and control in cystic fibrosis. Curr Opin Infect Dis 2011; 24: 390395.
  • 77
    Tingpej P, Elkins M, Rose B et al. Clinical profile of adult cystic fibrosis patients with frequent epidemic clones of Pseudomonas aeruginosa. Respirology 2010; 15: 923929.
  • 78
    Clifton U, Pecham DG. Defining routes of airborne transmission of Pseudomonas aeruginosa in people with cystic fibrosis. Expert Rev Respir Med 2010; 4: 519529.
  • 79
    Peleg AY, Seifert H, Paterson DL. Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev 2008; 21: 538582.
  • 80
    Abbo A, Navon-Venezia S, Hammer-Muntz O, Krichali T, Siegman-Igra Y, Carmeli Y. Multidrug-resistant Acinetobacter baumannii. Emerg Infect Dis 2005; 11: 2229.
  • 81
    Rodriguez-Bano J, Garcia L, Ramirez E et al. Long-term control of hospital-wide, endemic multidrug-resistant Acinetobacter baumannii through a comprehensive “bundle” approach. Am J Infect Control 2009; 37: 715722.
  • 82
    Fernandez-Cuenca F, Lopez-Cortes LE, Rodriguez-Bano J. The microbiology laboratory's contribution to the surveillance and control of outbreaks caused by nonfermentative Gram-negative bacilli. Enferm Infecc Microbiol Clin 2011; 29(Suppl 3): 4046.
  • 83
    VanCouwenberghe CJ, Cohen SH, Tang YJ, Gumerlock PH, Silva J Jr. Genomic fingerprinting of epidemic and endemic strains of Stenotrophomonas maltophilia (formerly Xanthomonas maltophilia) by arbitrarily primed PCR. J Clin Microbiol 1995; 33: 12891291.
  • 84
    Garcia de Viedma D, Marin M, Cercenado E, Alonso R, Rodriguez-Creixems M, Bouza E. Evidence of nosocomial Stenotrophomonas maltophilia cross-infection in a neonatology unit analyzed by three molecular typing methods. Infect Control Hosp Epidemiol 1999; 20: 816820.
  • 85
    Gulcan H, Kuzucu C, Durmaz R. Nosocomial Stenotrophomonas maltophilia cross-infection: three cases in newborns. Am J Infect Control 2004; 32: 365368.
  • 86
    Agodi A, Barchitta M, Giannino V et al. Burkholderia cepacia complex in cystic fibrosis and non-cystic fibrosis patients: identification of a cluster of epidemic lineages. J Hosp Infect 2002; 50: 188195.
  • 87
    Speert DP, Henry D, Vandamme P, Corey M, Mahenthiralingam E. Epidemiology of Burkholderia cepacia complex in patients with cystic fibrosis, Canada. Emerg Infect Dis 2002; 8: 181187.
  • 88
    Siddiqui AH, Mulligan ME, Mahenthiralingam E et al. An episodic outbreak of genetically related Burkholderia cepacia among non-cystic fibrosis patients at a university hospital. Infect Control Hosp Epidemiol 2001; 22: 419422.
  • 89
    Love GJ, Gezonhmthompson DJ, Rogers KD, Hatch TF. Relation of intensity of staphylococcal infection in newborn infants to contamination of nurses’ hands and surrounding environment. Pediatrics 1963; 32: 956965.
  • 90
    Guenthner SH, Hendley JO, Wenzel RP. Gram-negative bacilli as nontransient flora on the hands of hospital personnel. J Clin Microbiol 1987; 25: 488490.
  • 91
    Casewell MW, Desai N. Survival of multiply-resistant Klebsiella aerogenes and other Gram-negative bacilli on finger-tips. J Hosp Infect 1983; 4: 350360.
  • 92
    Sanderson PJ, Weissler S. Recovery of coliforms from the hands of nurses and patients: activities leading to contamination. J Hosp Infect 1992; 21: 8593.
  • 93
    Morgan DJ, Liang SY, Smith CL et al. Frequent multidrug-resistant Acinetobacter baumannii contamination of gloves, gowns, and hands of healthcare workers. Infect Control Hosp Epidemiol 2010; 31: 716721.
  • 94
    Grice EA, Segre JA. The skin microbiome. Nat Rev Microbiol 2011; 9: 244253.
  • 95
    Davis CP. Normal flora. In: Baron S, ed. Medical microbiology, 4th edn. Galveston, TX: University of Texas Medical Branch, 1996; Chapter 6. Available from:
  • 96
    Retailliau HF, Hightower AW, Dixon RE, Allen JR. Acinetobacter calcoaceticus: a nosocomial pathogen with an unusual seasonal pattern. J Infect Dis 1979; 139: 371375.
  • 97
    Larson EL, McGinley KJ, Foglia AR, Talbot GH, Leyden JJ. Composition and antimicrobic resistance of skin flora in hospitalized and healthy adults. J Clin Microbiol 1986; 23: 604608.
  • 98
    Hamamci N, Dursun E, Akbas E, Aktepe OC, Cakc A. A quantitative study of genital skin flora and urinary colonization in spinal cord injured patients. Spinal Cord 1998; 36: 617620.
  • 99
    Fawcett C, Chawla JC, Quoraishi A, Stickler DJ. A study of the skin flora of spinal cord injured patients. J Hosp Infect 1986; 8: 149158.
  • 100
    Seifert H, Dijkshoorn L, Gerner-Smidt P, Pelzer N, Tjernberg I, Vaneechoutte M. Distribution of Acinetobacter species on human skin: comparison of phenotypic and genotypic identification methods. J Clin Microbiol 1997; 35: 28192825.
  • 101
    Adams BG, Marrie TJ. Hand carriage of aerobic Gram-negative rods by health care personnel. J Hyg (Lond) 1982; 89: 2331.
  • 102
    Pittet D, Dharan S, Touveneau S, Sauvan V, Perneger TV. Bacterial contamination of the hands of hospital staff during routine patient care. Arch Intern Med 1999; 159: 821826.
  • 103
    Morgan DJ, Rogawski E, Thom KE et al. Transfer of multidrug-resistant bacteria to healthcare workers’ gloves and gowns after patient contact increases with environmental contamination. Crit Care Med 2012; 40: 10451051.
  • 104
    Musa EK, Desai N, Casewell MW. The survival of Acinetobacter calcoaceticus inoculated on fingertips and on formica. J Hosp Infect 1990; 15: 219227.
  • 105
    Fagernes M, Lingaas E. Factors interfering with the microflora on hands: a regression analysis of samples from 465 healthcare workers. J Adv Nurs 2011; 67: 297307.
  • 106
    McNeil SA, Foster CL, Hedderwick SA, Kauffman CA. Effect of hand cleansing with antimicrobial soap or alcohol-based gel on microbial colonization of artificial fingernails worn by health care workers. Clin Infect Dis 2001; 32: 367372.
  • 107
    Gordin FM, Schultz ME, Huber R, Zubairi S, Stock F, Kariyil J. A cluster of hemodialysis-related bacteremia linked to artificial fingernails. Infect Control Hosp Epidemiol 2007; 28: 743744.
  • 108
    Moolenaar RL, Crutcher JM, San Joaquin VH et al. A prolonged outbreak of P. aeruginosa in a neonatal intensive care unit: did staff fingernails play a role in disease transmission? Infect Control Hosp Epidemiol 2000; 21: 8085.
  • 109
    Paul R, Das NK, Dutta R, Bandyopadhyay R, Banerjee AK. Bacterial contamination of the hands of doctors: a study in the medicine and dermatology wards. Indian J Dermatol Venereol Leprol 2011; 77: 307313.
  • 110
    Cardoso CL, Pereira HH, Zequim JC, Guilhermetti M. Effectiveness of hand-cleansing agents for removing Acinetobacter baumannii strain from contaminated hands. Am J Infect Control 1999; 27: 327331.
  • 111
    Grundmann H, Hahn A, Ehrenstein B, Geiger K, Just H, Daschner FD. Detection of cross-transmission of multiresistant Gram-negative bacilli and Staphylococcus aureus in adult intensive care units by routine typing of clinical isolates. Clin Microbiol Infect 1999; 5: 355363.
  • 112
    Chetchotisakd P, Phelps CL, Hartstein AI. Assessment of bacterial cross-transmission as a cause of infections in patients in intensive care units. Clin Infect Dis 1994; 18: 929937.
  • 113
    Lingaas E, Fagernes M. Development of a method to measure bacterial transfer from hands. J Hosp Infect 2009; 72: 4349.
  • 114
    Wiener-Well Y, Galuty M, Rudensky B, Schlesinger Y, Attias D, Yinnon AM. Nursing and physician attire as possible source of nosocomial infections. Am J Infect Control 2011; 39: 555559.
  • 115
    Perry C, Marshall R, Jones E. Bacterial contamination of uniforms. J Hosp Infect 2001; 48: 238241.
  • 116
    Wilson JA, Loveday HP, Hoffman PN, Pratt RJ. Uniform: an evidence review of the microbiological significance of uniforms and uniform policy in the prevention and control of healthcare-associated infections. Report to the Department of Health (England). J Hosp Infect 2007; 66: 301307.
  • 117
    Babb JR, Davies JG, Ayliffe GA. Contamination of protective clothing and nurses’ uniforms in an isolation ward. J Hosp Infect 1983; 4: 149157.
  • 118
    Wong D, Nye K, Hollis P. Microbial flora on doctors’ white coats. BMJ 1991; 303: 16021604.
  • 119
    Speers R Jr, Shooter RA, Gaya H, Patel N. Contamination of nurses’ uniforms with Staphylococcus aureus. Lancet 1969; 2: 233235.
  • 120
    Ransjo U. Attempts to control clothes-borne infection in a burn unit, 3. An open-roofed plastic isolator or plastic aprons to prevent contact transfer of bacteria. J Hyg (Lond) 1979; 82: 385395.
  • 121
    Kotsanas D, Scott C, Gillespie EE, Korman TM, Stuart RL. What's hanging around your neck? Pathogenic bacteria on identity badges and lanyards. Med J Aust 2008; 188: 58.
  • 122
    Kochar S, Sheard T, Sharma R et al. Success of an infection control program to reduce the spread of carbapenem-resistant Klebsiella pneumoniae. Infect Control Hosp Epidemiol 2009; 30: 447452.
  • 123
    Laurent C, Rodriguez-Villalobos H, Rost F et al. Intensive care unit outbreak of extended-spectrum β-lactamase-producing Klebsiella pneumoniae controlled by cohorting patients and reinforcing infection control measures. Infect Control Hosp Epidemiol 2008; 29: 517524.
  • 124
    Lucet JC, Decre D, Fichelle A et al. Control of a prolonged outbreak of extended-spectrum β-lactamase-producing Enterobacteriaceae in a university hospital. Clin Infect Dis 1999; 29: 14111418.
  • 125
    Ben-David D, Maor Y, Keller N et al. Potential role of active surveillance in the control of a hospital-wide outbreak of carbapenem-resistant Klebsiella pneumoniae infection. Infect Control Hosp Epidemiol 2010; 31: 620626.
  • 126
    Ciobotaro P, Oved M, Nadir E, Bardenstein R, Zimhony O. An effective intervention to limit the spread of an epidemic carbapenem-resistant Klebsiella pneumoniae strain in an acute care setting: from theory to practice. Am J Infect Control 2011; 39: 671677.
  • 127
    Schwaber MJ, Lev B, Israeli A et al. Containment of a country-wide outbreak of carbapenem-resistant Klebsiella pneumoniae in Israeli hospitals via a nationally implemented intervention. Clin Infect Dis 2011; 52: 848855.
  • 128
    Langer AJ, Lafaro P, Genese CA, McDonough P, Nahass R, Robertson C. Using active microbiologic surveillance and enhanced infection control measures to control an outbreak of health care-associated extended-spectrum β-lactamase-producing Klebsiella pneumoniae infections–New Jersey, 2007. Am J Infect Control 2009; 37: 7375.
  • 129
    Wybo I, Blommaert L, De Beer T et al. Outbreak of multidrug-resistant Acinetobacter baumannii in a Belgian university hospital after transfer of patients from Greece. J Hosp Infect 2007; 67: 374380.
  • 130
    Monterrubio-Villar J, González-Velasco C, Valdezate-Ramos S, Córdoba-López A, Villalón-Panzano P, Saéz-Nieto JA. Outbreak of multiresistant Acinetobacter baumannii in a polyvalent intensive care unit: clinical, epidemiological analysis and PFGE-printing evolution. Eur J Clin Microbiol Infect Dis 2009; 28: 12811284.
  • 131
    Simor AE, Lee M, Vearncombe M et al. An outbreak due to multiresistant Acinetobacter baumannii in a burn unit: risk factors for acquisition and management. Infect Control Hosp Epidemiol 2002; 23: 261267.
  • 132
    Gbaguidi-Haore H, Legast S, Thouverez M, Bertrand X, Talon D. Ecological study of the effectiveness of isolation precautions in the management of hospitalized patients colonized or infected with Acinetobacter baumannii. Infect Control Hosp Epidemiol 2008; 29: 11181123.
  • 133
    Ling ML, Ang A, Wee M, Wang GC. A nosocomial outbreak of multiresistant Acinetobacter baumannii originating from an intensive care unit. Infect Control Hosp Epidemiol 2001; 22: 4849.
  • 134
    La Forgia C, Franke J, Hacek DM, Thomson RB Jr, Robicsek A, Peterson LR. Management of a multidrug-resistant Acinetobacter baumannii outbreak in an intensive care unit using novel environmental disinfection: a 38-month report. Am J Infect Control 2010; 38: 259263.
  • 135
    Nseir S, Blazejewski C, Lubret R, Wallet F, Courcol R, Durocher A. Risk of acquiring multidrug-resistant Gram-negative bacilli from prior room occupants in the intensive care unit. Clin Microbiol Infect 2011; 17: 12011208.
  • 136
    Troche G, Joly LM, Guibert M, Zazzo JF. Detection and treatment of antibiotic-resistant bacterial carriage in a surgical intensive care unit: a 6-year prospective survey. Infect Control Hosp Epidemiol 2005; 26: 161165.
  • 137
    Conterno LO, Shymanski J, Ramotar K, Toye B, Zvonar R, Roth V. Impact and cost of infection control measures to reduce nosocomial transmission of extended-spectrum β-lactamase-producing organisms in a non-outbreak setting. J Hosp Infect 2007; 65: 354360.
  • 138
    Urban C, Segal-Maurer S, Rahal JJ. Considerations in control and treatment of nosocomial infections due to multidrug-resistant Acinetobacter baumannii. Clin Infect Dis 2003; 36: 12681274.
  • 139
    Mattner F, Bange FC, Meyer E, Seifert H, Wichelhaus TA, Chaberny IF. Preventing the spread of multidrug-resistant Gram-negative pathogens: recommendations of an expert panel of the German Society for Hygiene and Microbiology. Dtsch Arztebl Int 2012; 109: 3945.
  • 140
    Kluytmans-Vandenbergh MF, Kluytmans JA, Voss A. Dutch guideline for preventing nosocomial transmission of highly resistant microorganisms (HRMO). Infection 2005; 33: 309313.
  • 141
    Mastoraki A, Douka E, Kriaras I, Stravopodis G, Saroglou G, Geroulanos S. Preventing strategy of multidrug-resistant Acinetobacter baumanii susceptible only to colistin in cardiac surgical intensive care units. Eur J Cardiothorac Surg 2008; 33: 10861090.
  • 142
    Vonberg RP, Wolter A, Chaberny IF et al. Epidemiology of multi-drug-resistant Gram-negative bacteria: data from an university hospital over a 36-month period. Int J Hyg Environ Health 2008; 211: 251257.
  • 143
    Harris AD, Nemoy L, Johnson JA et al. Co-carriage rates of vancomycin-resistant Enterococcus and extended-spectrum β-lactamase-producing bacteria among a cohort of intensive care unit patients: implications for an active surveillance program. Infect Control Hosp Epidemiol 2004; 25: 105108.
  • 144
    Maragakis LL, Tucker MG, Miller RG, Carroll KC, Perl TM. Incidence and prevalence of multidrug-resistant Acinetobacter using targeted active surveillance cultures. JAMA 2008; 299: 25132514.
  • 145
    Bratu S, Landman D, Haag R et al. Rapid spread of carbapenem-resistant Klebsiella pneumoniae in New York city: a new threat to our antibiotic armamentarium. Arch Intern Med 2005; 165: 14301435.
  • 146
    Corbella X, Pujol M, Ayats J et al. Relevance of digestive tract colonization in the epidemiology of nosocomial infections due to multiresistant Acinetobacter baumannii. Clin Infect Dis 1996; 23: 329334.
  • 147
    Snyder GM, D'Agata EM. Diagnostic accuracy of surveillance cultures to detect gastrointestinal colonization with multidrug-resistant gram-negative bacteria. Am J Infect Control 2012; 40: 474476.
  • 148
    Papadomichelakis E, Kontopidou F, Antoniadou A et al. Screening for resistant gram-negative microorganisms to guide empiric therapy of subsequent infection. Intensive Care Med 2008; 34: 21692175.
  • 149
    Buehlmann M, Fankhauser H, Laffer R, Bregenzer T, Widmer AF. The inguinal skin: an important site of colonization with extended-spectrum β-lactamase producing Enterobacteriaceae. Infect Control Hosp Epidemiol 2010; 31: 427428.
  • 150
    O'Fallon E, Gautam S, D'Agata EM. Colonization with multidrug-resistant gram-negative bacteria: prolonged duration and frequent cocolonization. Clin Infect Dis 2009; 48: 13751381.
  • 151
    Weintrob AC, Roediger MP, Barber M et al. Natural history of colonization with Gram-negative multidrug-resistant organisms among hospitalized patients. Infect Control Hosp Epidemiol 2010; 31: 330337.
  • 152
    Marchaim D, Navon-Venezia S, Schwartz D et al. Surveillance cultures and duration of carriage of multidrug-resistant Acinetobacter baumannii. J Clin Microbiol 2007; 45: 15511555.
  • 153
    Barbolla RE, Centron D, Maimone S et al. Molecular epidemiology of Acinetobacter baumannii spread in an adult intensive care unit under an endemic setting. Am J Infect Control 2008; 36: 444452.
  • 154
    Pasricha J, Koessler T, Harbarth S et al. Carriage of extended-spectrum β-lactamase-producing enterobacteriacae among internal medicine patients in Switzerland. Antimicrob Resist Infect Control 2013; 2: 20.
  • 155
    Harris AD, McGregor JC, Furuno JP. What infection control interventions should be undertaken to control multidrug-resistant Gram-negative bacteria? Clin Infect Dis 2006; 43(Suppl 2): S57S61.
  • 156
    Enoch DA, Summers C, Brown NM et al. Investigation and management of an outbreak of multidrug-carbapenem-resistant Acinetobacter baumannii in Cambridge, UK. J Hosp Infect 2008; 70: 109118.
  • 157
    Apisarnthanarak A, Pinitchai U, Thongphubeth K, Yuekyen C, Warren DK, Fraser VJ. A multifaceted intervention to reduce pandrug-resistant Acinetobacter baumannii colonization and infection in 3 intensive care units in a Thai tertiary care center: a 3-year study. Clin Infect Dis 2008; 47: 760767.
  • 158
    Dancer SJ. Hospital cleaning in the 21st century. Eur J Clin Microbiol Infect Dis 2011; 30: 14731481.
  • 159
    Weber DJ, Rutala WA, Miller MB, Huslage K, Sickbert-Bennett E. Role of hospital surfaces in the transmission of emerging health care-associated pathogens: Norovirus, Clostridium difficile, and Acinetobacter species. Am J Infect Control 2010; 38: S25S33.
  • 160
    Corbella X, Pujol M, Argerich MJ et al. Environmental sampling of Acinetobacter baumannii: moistened swabs versus moistened sterile gauze pads. Infect Control Hosp Epidemiol 1999; 20: 458460.
  • 161
    Dancer SJ. Mopping up hospital infection. J Hosp Infect 1999; 43: 85100.
  • 162
    Kramer A, Schwebke I, Kampf G. How long do nosocomial pathogens persist on inanimate surfaces? A systematic review. BMC Infect Dis 2006; 6: 130.
  • 163
    Denton M, Wilcox MH, Parnell P et al. Role of environmental cleaning in controlling an outbreak of Acinetobacter baumannii on a neurosurgical intensive care unit. J Hosp Infect 2004; 56: 106110.
  • 164
    Wendt C, Dietze B, Dietz E, Ruden H. Survival of Acinetobacter baumannii on dry surfaces. J Clin Microbiol 1997; 35: 13941397.
  • 165
    Wagenvoort JH, Sluijsmans W, Penders RJ. Better environmental survival of outbreak vs. sporadic MRSA isolates. J Hosp Infect 2000; 45: 231234.
  • 166
    Sanderson PJ, Rawal P. Contamination of the environment of spinal cord injured patients by organisms causing urinary-tract infection. J Hosp Infect 1987; 10: 173178.
  • 167
    Sanderson PJ, Alshafi KM. Environmental contamination by organisms causing urinary tract infection. J Hosp Infect 1995; 29: 301303.
  • 168
    Lemmen SW, Hafner H, Zolldann D, Stanzel S, Lutticken R. Distribution of multi-resistant Gram-negative versus Gram-positive bacteria in the hospital inanimate environment. J Hosp Infect 2004; 56: 191197.
  • 169
    Getchell-White SI, Donowitz LG, Groschel DH. The inanimate environment of an intensive care unit as a potential source of nosocomial bacteria: evidence for long survival of Acinetobacter calcoaceticus. Infect Control Hosp Epidemiol 1989; 10: 402407.
  • 170
    Joynson DH. Bowls and bacteria. J Hyg (Lond) 1978; 80: 423425.
  • 171
    Dancer SJ, Coyne M, Robertson C, Thomson A, Guleri A, Alcock S. Antibiotic use is associated with resistance of environmental organisms in a teaching hospital. J Hosp Infect 2006; 62: 200206.
  • 172
    D'Agata EM, Venkataraman L, DeGirolami P, Samore M. Molecular epidemiology of ceftazidime-resistant gram-negative bacilli on inanimate surfaces and their role in cross-transmission during non-outbreak periods. J Clin Microbiol 1999; 37: 30653067.
  • 173
    Mitchell BG, Wilson F, McGregor A, Dancer SJ. Methods to evaluate environmental cleanliness in healthcare facilities. Healthcare Infection 2013; 18: 2330.
  • 174
    Hota S, Hirji Z, Stockton K et al. Outbreak of multidrug-resistant Pseudomonas aeruginosa colonization and infection secondary to imperfect intensive care unit room design. Infect Control Hosp Epidemiol 2009; 30: 2533.
  • 175
    Doring G, Ulrich M, Muller W et al. Generation of Pseudomonas aeruginosa aerosols during handwashing from contaminated sink drains, transmission to hands of hospital personnel, and its prevention by use of a new heating device. Zentralbl Hyg Umweltmed 1991; 191: 494505.
  • 176
    Weber DJ, Rutala WA, Blanchet CN, Jordan M, Gergen MF. Faucet aerators: a source of patient colonization with Stenotrophomonas maltophilia. Am J Infect Control 1999; 27: 5963.
  • 177
    Panagea S, Winstanley C, Walshaw MJ, Ledson MJ, Hart CA. Environmental contamination with an epidemic strain of Pseudomonas aeruginosa in a Liverpool cystic fibrosis centre, and study of its survival on dry surfaces. J Hosp Infect 2005; 59: 102107.
  • 178
    Doring G, Jansen S, Noll H et al. Distribution and transmission of Pseudomonas aeruginosa and Burkholderia cepacia in a hospital ward. Pediatr Pulmonol 1996; 21: 90100.
  • 179
    Hobson RP, MacKenzie FM, Gould IM. An outbreak of multiply-resistant Klebsiella pneumoniae in the Grampian region of Scotland. J Hosp Infect 1996; 33: 249262.
  • 180
    Lucero CA, Cohen AL, Trevino I et al. Outbreak of Burkholderia cepacia complex among ventilated pediatric patients linked to hospital sinks. Am J Infect Control 2011; 39: 775778.
  • 181
    Cross DF, Benchimol A, Dimond EG. The faucet aerator – a source of Pseudomonas infection. N Engl J Med 1966; 274: 14301431.
  • 182
    Costerton JW, Cheng KJ, Geesey GG et al. Bacterial biofilms in nature and disease. Annu Rev Microbiol 1987; 41: 435464.
  • 183
    Yang D, Zhang Z. Biofilm-forming Klebsiella pneumoniae strains have greater likelihood of producing extended-spectrum β-lactamases. J Hosp Infect 2008; 68: 369371.
  • 184
    Rutala WA, Weber DJ. Uses of inorganic hypochlorite (bleach) in health-care facilities. Clin Microbiol Rev 1997; 10: 597610.
  • 185
    McAllister TA, Lucas CE, Mocan H et al. Serratia marcescens outbreak in a paediatric oncology unit traced to contaminated chlorhexidine. Scott Med J 1989; 34: 525528.
  • 186
    Wishart MM, Riley TV. Infection with Pseudomonas maltophilia hospital outbreak due to contaminated disinfectant. Med J Aust 1976; 2: 710712.
  • 187
    Werry C, Lawrence JM, Sanderson PJ. Contamination of detergent cleaning solutions during hospital cleaning. J Hosp Infect 1988; 11: 4449.
  • 188
    Medcraft JW, Hawkins JM, Fletcher BN, Dadswell JV. Potential hazard from spray cleaning of floors in hospital wards. J Hosp Infect 1987; 9: 151157.
  • 189
    Engelhart S, Krizek L, Glasmacher A, Fischnaller E, Marklein G, Exner M. Pseudomonas aeruginosa outbreak in a haematology-oncology unit associated with contaminated surface cleaning equipment. J Hosp Infect 2002; 52: 9398.
  • 190
    Forder AA. Buckets and mops in operating-theatres. Lancet 1973; 1: 1325.
  • 191
    Davies A, Pottage T, Bennett A, Walker J. Gaseous and air decontamination technologies for Clostridium difficile in the healthcare environment. J Hosp Infect 2011; 77: 199203.
  • 192
    Mandal J, Kate A, Parija SC. Microbicidal effect of electrolysed detergent water. J Hosp Infect 2010; 76: 9495.
  • 193
    Song L, Wu J, Xi C. Biofilms on environmental surfaces: evaluation of the disinfection efficacy of a novel steam vapor system. Am J Infect Control 2012; 40: 926930.
  • 194
    Otter JA, Yezli S, Schouten MA, van Zanten AR, Houmes-Zielman G, Nohlmans-Paulssen MK. Hydrogen peroxide vapor decontamination of an intensive care unit to remove environmental reservoirs of multidrug-resistant Gram-negative rods during an outbreak. Am J Infect Control 2010; 38: 754756.
  • 195
    Sharma M, Hudson JB. Ozone gas is an effective and practical antibacterial agent. Am J Infect Control 2008; 36: 559563.
  • 196
    Maclean M, Macgregor SJ, Anderson JG et al. Environmental decontamination of a hospital isolation room using high-intensity narrow-spectrum light. J Hosp Infect 2010; 76: 247251.
  • 197
    Meunier O, Meistermann C, Schwebel A. Effectiveness and limits of the cleaners steam in hospitals. Pathol Biol (Paris) 2009; 57: 252257.
  • 198
    Falagas ME, Thomaidis PC, Kotsantis IK, Sgouros K, Samonis G, Karageorgopoulos DE. Airborne hydrogen peroxide for disinfection of the hospital environment and infection control: a systematic review. J Hosp Infect 2011; 78: 171177.
  • 199
    Nerandzic MM, Cadnum JL, Pultz MJ, Donskey CJ. Evaluation of an automated ultraviolet radiation device for decontamination of Clostridium difficile and other healthcare-associated pathogens in hospital rooms. BMC Infect Dis 2010; 10: 197.
  • 200
    Memarzadeh F, Olmsted RN, Bartley JM. Applications of ultraviolet germicidal irradiation disinfection in health care facilities: effective adjunct, but not stand-alone technology. Am J Infect Control 2010; 38: S13S24.
  • 201
    Sweeney CP, Dancer SJ. Can hospital computers be disinfected using a hand-held UV light source? J Hosp Infect 2009; 72: 9294.
  • 202
    Sattar SA. Promises and pitfalls of recent advances in chemical means of preventing the spread of nosocomial infections by environmental surfaces. Am J Infect Control 2010; 38: S34S40.
  • 203
    Moore G, Griffith C. A laboratory evaluation of the decontamination properties of microfibre cloths. J Hosp Infect 2006; 64: 379385.
  • 204
    Griffith CJ, Dancer SJ. Hospital cleaning: problems with steam cleaning and microfibre. J Hosp Infect 2009; 72: 360361.
  • 205
    Bergen LK, Meyer M, Hog M, Rubenhagen B, Andersen LP. Spread of bacteria on surfaces when cleaning with microfibre cloths. J Hosp Infect 2009; 71: 132137.
  • 206
    Page K, Wilson M, Parkin IP. Antimicrobial surfaces and their potential in reducing the role of the inanimate environment in the incidence of hospital-acquired infections. J Mater Chem 2009; 19: 38193831.
  • 207
    Su W, Wei SS, Hu SQ, Tang JX. Preparation of tio(2)/ag colloids with ultraviolet resistance and antibacterial property using short chain polyethylene glycol. J Hazard Mater 2009; 172: 716720.
  • 208
    Airey P, Verran J. Potential use of copper as a hygienic surface; problems associated with cumulative soiling and cleaning. J Hosp Infect 2007; 67: 271277.
  • 209
    Tankovic J, Legrand P, De Gatines G, Chemineau V, Brun-Buisson C, Duval J. Characterization of a hospital outbreak of imipenem-resistant Acinetobacter baumannii by phenotypic and genotypic typing methods. J Clin Microbiol 1994; 32: 26772681.
  • 210
    Scerpella EG, Wanger AR, Armitige L, Anderlini P, Ericsson CD. Nosocomial outbreak caused by a multiresistant clone of Acinetobacter baumannii: results of the case–control and molecular epidemiologic investigations. Infect Control Hosp Epidemiol 1995; 16: 9297.
  • 211
    Valencia R, Arroyo LA, Conde M et al. Nosocomial outbreak of infection with pan-drug-resistant Acinetobacter baumannii in a tertiary care university hospital. Infect Control Hosp Epidemiol 2009; 30: 257263.
  • 212
    Neely AN, Maley MP, Warden GD. Computer keyboards as reservoirs for Acinetobacter baumannii in a burn hospital. Clin Infect Dis 1999; 29: 13581360.
  • 213
    Randrianirina F, Vedy S, Rakotovao D et al. Role of contaminated aspiration tubes in nosocomial outbreak of Klebsiella pneumoniae producing SHV-2 and CTX-M-15 extended-spectrum β-lactamases. J Hosp Infect 2009; 72: 2329.
  • 214
    Das I, Lambert P, Hill D, Noy M, Bion J, Elliott T. Carbapenem-resistant Acinetobacter and role of curtains in an outbreak in intensive care units. J Hosp Infect 2002; 50: 110114.
  • 215
    Dancer SJ. The role of environmental cleaning in the control of hospital-acquired infection. J Hosp Infect 2009; 73: 378385.
  • 216
    Goddard S, Muller MP. The efficacy of infection control interventions in reducing the incidence of extended-spectrum β-lactamase-producing Enterobacteriaceae in the nonoutbreak setting: a systematic review. Am J Infect Control 2011; 39: 599601.
  • 217
    Soulier A, Barbut F, Ollivier JM, Petit JC, Lienhart A. Decreased transmission of Enterobacteriaceae with extended-spectrum β-lactamases in an intensive care unit by nursing reorganization. J Hosp Infect 1995; 31: 8997.
  • 218
    Virgincar N, Iyer S, Stacey A et al. Klebsiella pneumoniae producing KPC carbapenemase in a district general hospital in the UK. J Hosp Infect 2011; 78: 293296.
  • 219
    Tacconelli E, De Angelis G, Cataldo MA, Pozzi E, Cauda R. Does antibiotic exposure increase the risk of methicillin-resistant Staphylococcus aureus (MRSA) isolation? A systematic review and meta-analysis. J Antimicrob Chemother 2008; 61: 2638.
  • 220
    Tacconelli E, De Angelis G, Cataldo MA et al. Antibiotic usage and risk of colonization and infection with antibiotic-resistant bacteria: a hospital population-based study. Antimicrob Agents Chemother 2009; 53: 42644269.
  • 221
    Tacconelli E, Cataldo MA, De Pascale G et al. Prediction models to identify hospitalized patients at risk of being colonized or infected with multidrug-resistant Acinetobacter baumannii calcoaceticus complex. J Antimicrob Chemother 2008; 62: 11301137.
  • 222
    Tinelli M, Cataldo MA, Mantengoli E et al. Epidemiology and genetic characteristics of extended-spectrum β-lactamase-producing Gram-negative bacteria causing urinary tract infections in long-term care facilities. J Antimicrob Chemother 2012; 67: 29822987.
  • 223
    Davey P, Brown E, Charani E et al. Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database Syst Rev 2013; Issue 4. Art. No.: CD003543. DOI: 10.1002/14651858.CD003543.pub3.
  • 224
    Gerding DN, Larson TA, Hughes RA, Weiler M, Shanholtzer C, Peterson LR. Aminoglycoside resistance and aminoglycoside usage: ten years of experience in one hospital. Antimicrob Agents Chemother 1991; 35: 12841290.
  • 225
    Ntagiopoulos PG, Paramythiotou E, Antoniadou A, Giamarellou H, Karabinis A. Impact of an antibiotic restriction policy on the antibiotic resistance patterns of Gram-negative microorganisms in an intensive care unit in Greece. Int J Antimicrob Agents 2007; 30: 360365.
  • 226
    Altunsoy A, Aypak C, Azap A, Ergönül Ö, Balık I. The impact of a nationwide antibiotic restriction program on antibiotic usage and resistance against nosocomial pathogens in Turkey. Int J Med Sci 2011; 4: 339344.
  • 227
    Malani AN, Richards PG, Kapila S, Otto MH, Czerwinski J, Singal B. Clinical and economic outcomes from a community hospital's antimicrobial stewardship program. Am J Infect Control 2012; 41: 145148.
  • 228
    de Man P, Verhoeven BA, Verbrugh HA, Vos MC, van den Anker JN. An antibiotic policy to prevent emergence of resistant bacilli. Lancet 2000; 355: 973978.
  • 229
    Meyer KS, Urban C, Eagan JA, Berger BJ, Rahal JJ. Nosocomial outbreak of Klebsiella infection resistant to late-generation cephalosporins. Ann Intern Med 1993; 119: 353358.
  • 230
    Slain D, Sarwari AR, Petros KO et al. Impact of a multimodal antimicrobial stewardship program on Pseudomonas aeruginosa susceptibility and antimicrobial use in the intensive care unit setting. Crit Care Res Pract 2011; 2011: 416426.
  • 231
    Hirschman SZ, Meyers BR, Bradbury K, Mehl B, Gendelman S, Kimelblatt B. Use of antimicrobial agents in a university teaching hospital. Evolution of a comprehensive control program. Arch Intern Med 1988; 148: 20012007.
  • 232
    McGowan JE Jr. Minimizing antimicrobial resistance: the key role of the infectious diseases physician. Clin Infect Dis 2004; 38: 939942.
  • 233
    Frank MO, Batteiger BE, Sorensen SJ et al. Decrease in expenditures and selected nosocomial infections following implementation of an antimicrobial-prescribing improvement program. Clin Perform Qual Health Care 1997; 5: 180188.
  • 234
    Kollef MH, Vlasnik J, Sharpless L, Pasque C, Murphy D, Fraser V. Scheduled change of antibiotic classes: a strategy to decrease the incidence of ventilator-associated pneumonia. Am J Respir Crit Care Med 1997; 156: 10401048.
  • 235
    Raymond DP, Pelletier SJ, Crabtree TD et al. Impact of a rotating empiric antibiotic schedule on infectious mortality in an intensive care unit. Crit Care Med 2001; 29: 11011108.
  • 236
    Dominguez EA, Smith TL, Reed E, Sanders CC, Sanders WE Jr. A pilot study of antibiotic cycling in a hematology-oncology unit. Infect Control Hosp Epidemiol 2000; 21: S4S8.
  • 237
    McGowan JE Jr. Strategies for study of the role of cycling on antimicrobial use and resistance. Infect Control Hosp Epidemiol 2000; 21: S36S43.
  • 238
    John JF Jr, Rice LB. The microbial genetics of antibiotic cycling. Infect Control Hosp Epidemiol 2000; 21: S22S31.
  • 239
    Raymond DP, Pelletier SJ, Sawyer RG. Antibiotic utilization strategies to limit antimicrobial resistance. Semin Respir Crit Care Med 2002; 23: 497501.
  • 240
    Molstad S, Cars O. Major change in the use of antibiotics following a national programme: Swedish strategic programme for the rational use of antimicrobial agents and surveillance of resistance (STRAMA). Scand J Infect Dis 1999; 31: 191195.
  • 241
    Leibovici L, Gitelman V, Yehezkelli Y et al. Improving empirical antibiotic treatment: prospective, nonintervention testing of a decision support system. J Intern Med 1997; 242: 395400.
  • 242
    Watkins C, Harvey I, Langley C, Gray S, Faulkner A. General practitioners’ use of guidelines in the consultation and their attitudes to them. Br J Gen Pract 1999; 49: 1115.
  • 243
    Yong MK, Buising KL, Cheng AC, Thursky KA. Improved susceptibility of Gram-negative bacteria in an intensive care unit following implementation of a computerized antibiotic decision support system. J Antimicrob Chemother 2010; 65: 10621069.
  • 244
    McGowan JE Jr, Tenover FC. Control of antimicrobial resistance in the health care system. Infect Dis Clin North Am 1997; 11: 297311.
  • 245
    White AC Jr, Atmar RL, Wilson J, Cate TR, Stager CE, Greenberg SB. Effects of requiring prior authorization for selected antimicrobials: expenditures, susceptibilities, and clinical outcomes. Clin Infect Dis 1997; 25: 230239.
  • 246
    Kim JY, Sohn JW, Park DW, Yoon YK, Kim YM, Kim MJ. Control of extended-spectrum β-lactamase-producing Klebsiella pneumoniae using a computer-assisted management program to restrict third-generation cephalosporin use. J Antimicrob Chemother 2008; 62: 416421.
  • 247
    Lautenbach E, Metlay JP, Weiner MG et al. Gastrointestinal tract colonization with fluoroquinolone-resistant Escherichia coli in hospitalized patients: changes over time in risk factors for resistance. Infect Control Hosp Epidemiol 2009; 30: 1824.
  • 248
    Lopez-Lozano JM, Monnet DL, Yague A et al. Modelling and forecasting antimicrobial resistance and its dynamic relationship to antimicrobial use: a time series analysis. Int J Antimicrob Agents 2000; 14: 2131.
  • 249
    Rice LB, Eckstein EC, DeVente J, Shlaes DM. Ceftazidime-resistant Klebsiella pneumoniae isolates recovered at the Cleveland Department of Veterans Affairs Medical Center. Clin Infect Dis 1996; 23: 118124.
  • 250
    Rahal JJ, Urban C, Horn D et al. Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella. JAMA 1998; 280: 12331237.
  • 251
    Burke JP. Antibiotic resistance – squeezing the balloon? JAMA 1998; 280: 12701271.
  • 252
    Rahal JJ, Urban C, Segal-Maurer S. Nosocomial antibiotic resistance in multiple Gram-negative species: experience at one hospital with squeezing the resistance balloon at multiple sites. Clin Infect Dis 2002; 34: 499503.
  • 253
    Brun-Buisson C, Legrand P, Rauss A et al. Intestinal decontamination for control of nosocomial multiresistant Gram-negative bacilli. Study of an outbreak in an intensive care unit. Ann Intern Med 1989; 110: 873881.
  • 254
    Taylor ME, Oppenheim BA. Selective decontamination of the gastrointestinal tract as an infection control measure. J Hosp Infect 1991; 17: 271278.
  • 255
    Huttner B, Haustein H, Uckay I et al. Decolonization of intestinal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae with oral colistin and neomycin: a randomized, double-blind, placebo-controlled trial. J Antimicrob Chemother 2013; 68: 23752382.
  • 256
    Saidel-Odes L, Polachek H, Peled N et al. A randomized, double-blind, placebo-controlled trial of selective digestive decontamination using oral gentamicin and oral polymyxin E for eradication of carbapenem-resistant Klebsiella pneumoniae carriage. Infect Control Hosp Epidemiol 2012; 33: 1419.
  • 257
    Vernon MO, Hayden MK, Trick WE, Hayes RA, Blom DW, Weinstein RA. Chlorhexidine gluconate to cleanse patients in a medical intensive care unit: the effectiveness of source control to reduce the bioburden of vancomycin-resistant Enterococci. Arch Intern Med 2006; 166: 306312.
  • 258
    Climo MW, Yokoe DS, Warren DK et al. Effect of daily chlorhexidine bathing on hospital-acquired infection. N Engl J Med 2013; 368: 533542.
  • 259
    Huang SS, Septimus E, Kleinman K et al. Targeted versus universal decolonization to prevent ICU infection. N Engl J Med 2013; 368: 22552265.
  • 260
    Evans HL, Dellit TH, Chan J, Nathens AB, Maier RV, Cuschieri J. Effect of chlorhexidine whole-body bathing on hospital-acquired infections among trauma patients. Arch Surg 2010; 145: 240246.
  • 261
    Munoz-Price LS, Hayden MK, Lolans K et al. Successful control of an outbreak of Klebsiella pneumoniae carbapenemase-producing K. pneumoniae at a long-term acute care hospital. Infect Control Hosp Epidemiol 2010; 31: 341347.
  • 262
    Akova M, Daikos GL, Tzouvelekis L, Carmeli Y. Interventional strategies and current clinical experience with carbapenemase-producing Gram-negative bacteria. Clin Microbiol Infect 2012; 18: 439448.
  • 263
    Stickler DJ. Susceptibility of antibiotic resistant Gram-negative bacteria to biocides: a perspective from the study of catheter biofilms. J Appl Microbiol 2002; 92(Suppl): 163S170S.
  • 264
    van‘t Veen A, van der Zee A, Nelson J, Speelberg B, Kluytmans JA, Buiting AG. Outbreak of infection with a multiresistant Klebsiella pneumoniae strain associated with contaminated roll boards in operating rooms. J Clin Microbiol 2005; 43: 49614967.
  • 265
    Cohen MJ, Block C, Levin PD et al. Institutional control measures to curtail the epidemic spread of carbapenem-resistant Klebsiella pneumoniae: a 4-year perspective. Infect Control Hosp Epidemiol 2011; 32: 673678.
  • 266
    Eveillard M, Eb F, Tramier B et al. Evaluation of the contribution of isolation precautions in prevention and control of multi-resistant bacteria in a teaching hospital. J Hosp Infect 2001; 47: 116124.
  • 267
    Souweine B, Traore O, Aublet-Cuvelier B et al. Role of infection control measures in limiting morbidity associated with multi-resistant organisms in critically ill patients. J Hosp Infect 2000; 45: 107116.
  • 268
    Martínez JA, Nicolás JM, Marco F et al. Comparison of antimicrobial cycling and mixing strategies in two medical intensive care units. Crit Care Med 2006; 34: 329336.
  • 269
    Marra AR, de Almeida SM, Correa L et al. The effect of limiting antimicrobial therapy duration on antimicrobial resistance in the critical care setting. Am J Infect Control 2009; 37: 204209.
  • 270
    Lipworth AD, Hyle EP, Fishman NO et al. Limiting the emergence of extended-spectrum β-lactamase-producing Enterobacteriaceae: influence of patient population characteristics on the response to antimicrobial formulary interventions. Infect Control Hosp Epidemiol 2006; 27: 279286.
  • 271
    Wen Z, Wei X, Xiao Y et al. Intervention study of the association of antibiotic utilization measures with control of extended-spectrum β-lactamase (ESBL)-producing bacteria. Microbes Infect 2010; 12: 710715.
  • 272
    Raineri E, Crema L, Dal Zoppo S et al. Rotation of antimicrobial therapy in the intensive care unit: impact on incidence of ventilator-associated pneumonia caused by antibiotic-resistant Gram-negative bacteria. Eur J Clin Microbiol Infect Dis 2010; 29: 10151024.
  • 273
    Bisson G, Fishman NO, Patel JB, Edelstein PH, Lautenbach E. Extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella species: risk factors for colonization and impact of antimicrobial formulary interventions on colonization prevalence. Infect Control Hosp Epidemiol 2002; 23: 254260.
  • 274
    Trick WE, Vernon MO, Welbel SF, Demarais P, Hayden MK, Weinstein RA. Multicenter intervention program to increase adherence to hand hygiene recommendations and glove use and to reduce the incidence of antimicrobial resistance. Infect Control Hosp Epidemiol 2007; 28: 4249.
  • 275
    Pires dos Santos R, Jacoby T, Pires Machado D et al. Hand hygiene, and not ertapenem use, contributed to reduction of carbapenem-resistant Pseudomonas aeruginosa rates. Infect Control Hosp Epidemiol 2011; 32: 584590.
  • 276
    Fukigai S, Alba J, Kimura S et al. Nosocomial outbreak of genetically related IMP-1 β-lactamase-producing Klebsiella pneumoniae in a general hospital in Japan. Int J Antimicrob Agents 2007; 29: 306310.
  • 277
    Gregory CJ, Llata E, Stine N et al. Outbreak of carbapenem-resistant Klebsiella pneumoniae in Puerto Rico associated with a novel carbapenemase variant. Infect Control Hosp Epidemiol 2010; 31: 476484.
  • 278
    Kassis-Chikhani N, Saliba F, Carbonne A et al. Extended measures for controlling an outbreak of VIM-1 producing imipenem-resistant Klebsiella pneumoniae in a liver transplant centre in France, 2003–2004. Euro Surveill 2010; 15 (46).
  • 279
    Ransjö U, Lytsy B, Melhus A et al. Hospital outbreak control requires joint efforts from hospital management, microbiology and infection control. J Hosp Infect 2010; 76: 2631.
  • 280
    Alsterlund R, Carlsson B, Gezelius L, Haeggman S, Olsson-Liljequist B. Multiresistant CTX-M-15 ESBL-producing Escherichia coli in southern Sweden: description of an outbreak. Scand J Infect Dis 2009; 41: 410415.
  • 281
    Paauw A, Verhoef J, Fluit AC et al. Failure to control an outbreak of qnrA1-positive multidrug-resistant Enterobacter cloacae infection despite adequate implementation of recommended infection control measures. J Clin Microbiol 2007; 45: 14201425.
  • 282
    Peña C, Pujol M, Ardanuy C et al. Epidemiology and successful control of a large outbreak due to Klebsiella pneumoniae producing extended-spectrum β-lactamases. Antimicrob Agents Chemother 1998; 42: 5358.
  • 283
    Ohana S, Denys P, Guillemot D et al. Control of an ACC-1-producing Klebsiella pneumoniae outbreak in a physical medicine and rehabilitation unit. J Hosp Infect 2006; 63: 3438.
  • 284
    Herbert S, Halvorsen DS, Leong T, Franklin C, Harrington G, Spelman D. Large outbreak of infection and colonization with Gram-negative pathogens carrying the metallo-β-lactamase gene blaIMP-4 at a 320-bed tertiary hospital in Australia. Infect Control Hosp Epidemiol 2007; 28: 98101.
  • 285
    Munoz-Price LS, De La Cuesta C, Adams S et al. Successful eradication of a monoclonal strain of Klebsiella pneumoniae during a K. pneumoniae carbapenemase-producing K. pneumoniae outbreak in a surgical intensive care unit in Miami, Florida. Infect Control Hosp Epidemiol 2010; 31: 10741077.
  • 286
    Wendt C, Schütt S, Dalpke AH et al. First outbreak of Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae in Germany. Eur J Clin Microbiol Infect Dis 2010; 29: 563570.
  • 287
    Endimiani A, Depasquale JM, Forero S et al. Emergence of BLAKPC-containing Klebsiella pneumoniae in a long-term acute care hospital: a new challenge to our healthcare system. J Antimicrob Chemother 2009; 64: 11021110.
  • 288
    Lee SO, Lee ES, Park SY, Kim SY, Seo YH, Cho YK. Reduced use of third-generation cephalosporins decreases the acquisition of extended-spectrum β-lactamase-producing Klebsiella pneumoniae. Infect Control Hosp Epidemiol 2004; 25: 832837.
  • 289
    Corbella X, Montero A, Pujol M et al. Emergence and rapid spread of carbapenem resistance during a large and sustained hospital outbreak of multiresistant Acinetobacter baumannii. J Clin Microbiol 2000; 38: 40864095.
  • 290
    Choi WS, Kim SH, Jeon EG et al. Nosocomial outbreak of carbapenem-resistant Acinetobacter baumannii in intensive care units and successful outbreak control program. J Korean Med Sci 2010; 25: 9991004.
  • 291
    Crowe M, Towner KJ, Humphreys H. Clinical and epidemiological features of an outbreak of Acinetobacter infection in an intensive therapy unit. J Med Microbiol 1995; 43: 5562.
  • 292
    Fierobe L, Lucet JC, Decré D et al. An outbreak of imipenem-resistant Acinetobacter baumannii in critically ill surgical patients. Infect Control Hosp Epidemiol 2001; 22: 3540.
  • 293
    Koeleman JG, Parlevliet GA, Dijkshoorn L, Savelkoul PH, Vandenbroucke-Grauls CM. Nosocomial outbreak of multi-resistant Acinetobacter baumannii on a surgical ward: epidemiology and risk factors for acquisition. J Hosp Infect 1997; 37: 113123.
  • 294
    Kohlenberg A, Brümmer S, Higgins PG et al. Outbreak of carbapenem-resistant Acinetobacter baumannii carrying the carbapenemase OXA-23 in a German university medical centre. J Med Microbiol 2009; 58: 14991507.
  • 295
    Ahmed J, Brutus A, D'Amato RF, Glatt AE. Acinetobacter calcoaceticus anitratus outbreak in the intensive care unit traced to a peak flow meter. Am J Infect Control 1994; 22: 319321.
  • 296
    Borgmann S, Wolz C, Gröbner S et al. Metallo-β-lactamase expressing multi-resistant Acinetobacter baumannii transmitted in the operation area. J Hosp Infect 2004; 57: 308315.
  • 297
    Go ES, Urban C, Burns J et al. Clinical and molecular epidemiology of Acinetobacter infections sensitive only to polymyxin B and sulbactam. Lancet 1994; 344: 13291332.
  • 298
    Jamal W, Salama M, Dehrab N, Al Hashem G, Shahin M, Rotimi VO. Role of tigecycline in the control of a carbapenem-resistant Acinetobacter baumannii outbreak in an intensive care unit. J Hosp Infect 2009; 72: 234242.
  • 299
    Longo B, Pantosti A, Luzzi I et al. Molecular findings and antibiotic-resistance in an outbreak of Acinetobacter baumannii in an intensive care unit. Ann Ist Super Sanita 2007; 43: 8388.
  • 300
    Naas T, Levy M, Hirschauer C, Marchandin H, Nordmann P. Outbreak of carbapenem-resistant Acinetobacter baumannii producing the carbapenemase OXA-23 in a tertiary care hospital of Papeete. French Polynesia. J Clin Microbiol 2005; 43: 48264829.
  • 301
    Orsi GB, Franchi C, Giordano A et al. Multidrug-resistant Acinetobacter baumannii outbreak in an intensive care unit. J Chemother 2008; 20: 219224.
  • 302
    Podnos YD, Cinat ME, Wilson SE, Cooke J, Gornick W, Thrupp LD. Eradication of multi-drug resistant Acinetobacter from an intensive care unit. Surg Infect (Larchmt) 2001; 2: 297301.
  • 303
    Wang SH, Sheng WH, Chang YY et al. Healthcare-associated outbreak due to pan-drug resistant Acinetobacter baumannii in a surgical intensive care unit. J Hosp Infect 2003; 53: 97102.
  • 304
    Crespo MP, Woodford N, Sinclair A et al. Outbreak of carbapenem-resistant Pseudomonas aeruginosa producing VIM-8, a novel metallo-β-lactamase, in a tertiary care center in Cali, Colombia. J Clin Microbiol 2004; 42: 50945101.
  • 305
    Peña C, Dominguez MA, Pujol M, Verdaguer R, Gudiol F, Ariza J. An outbreak of carbapenem-resistant Pseudomonas aeruginosa in a urology ward. Clin Microbiol Infect 2003; 9: 938943.
  • 306
    Cortes JA, Cuervo SI, Urdaneta AM et al. Identifying and controlling a multiresistant Pseudomonas aeruginosa outbreak in a Latin-American cancer centre and its associated risk factors. Braz J Infect Dis 2009; 13: 99103.
  • 307
    Kohlenberg A, Weitzel-Kage D, van der Linden P et al. Outbreak of carbapenem-resistant Pseudomonas aeruginosa infection in a surgical intensive care unit. J Hosp Infect 2010; 74: 350357.
  • 308
    Nagao M, Iinuma Y, Igawa J et al. Control of an outbreak of carbapenem-resistant Pseudomonas aeruginosa in a haemato-oncology unit. J Hosp Infect 2011; 79: 4953.
  • 309
    D'Agata EM, Thayer V, Schaffner W. An outbreak of Acinetobacter baumannii: the importance of cross-transmission. Infect Control Hosp Epidemiol 2000; 21: 588591.
  • 310
    Young LS, Sabel AL, Price CS. Epidemiologic, clinical, and economic evaluation of an outbreak of clonal multidrug-resistant Acinetobacter baumannii infection in a surgical intensive care unit. Infect Control Hosp Epidemiol 2007; 28: 12471254.
  • 311
    Doidge M, Allworth AM, Woods M et al. Control of an outbreak of carbapenem-resistant Acinetobacter baumannii in Australia after introduction of environmental cleaning with a commercial oxidizing disinfectant. Infect Control Hosp Epidemiol 2010; 31: 418420.
  • 312
    Richard P, Le Floch R, Chamoux C, Pannier M, Espaze E, Richet H. Pseudomonas aeruginosa outbreak in a burn unit: role of antimicrobials in the emergence of multiply resistant strains. J Infect Dis 1994; 170: 377383.
  • 313
    Richet H, Escande MC, Marie JP, Zittoun R, Lagrange PH. Epidemic Pseudomonas aeruginosa serotype O16 bacteremia in hematology-oncology patients. J Clin Microbiol 1989; 27: 19921996.
  • 314
    Bert F, Maubec E, Bruneau B, Berry P, Lambert-Zechovsky N. Multi-resistant Pseudomonas aeruginosa outbreak associated with contaminated tap water in a neurosurgery intensive care unit. J Hosp Infect 1998; 39: 5362.
  • 315
    Alfieri N, Ramotar K, Armstrong P et al. Two consecutive outbreaks of Stenotrophomonas maltophilia (Xanthomonas maltophilia) in an intensive-care unit defined by restriction fragment-length polymorphism typing. Infect Control Hosp Epidemiol 1999; 20: 553556.
  • 316
    Hamill RJ, Houston ED, Georghiou PR et al. An outbreak of Burkholderia (formerly Pseudomonas) cepacia respiratory tract colonization and infection associated with nebulized albuterol therapy. Ann Intern Med 1995; 122: 762766.
  • 317
    Heo ST, Kim SJ, Jeong YG, Bae IG, Jin JS, Lee JC. Hospital outbreak of Burkholderia stabilis bacteraemia related to contaminated chlorhexidine in haematological malignancy patients with indwelling catheters. J Hosp Infect 2008; 70: 241245.
  • 318
    Reboli AC, Koshinski R, Arias K, Marks-Austin K, Stieritz D, Stull TL. An outbreak of Burkholderia cepacia lower respiratory tract infection associated with contaminated albuterol nebulization solution. Infect Control Hosp Epidemiol 1996; 17: 741743.
  • 319
    Ramsey AH, Skonieczny P, Coolidge DT, Kurzynski TA, Proctor ME, Davis JP. Burkholderia cepacia lower respiratory tract infection associated with exposure to a respiratory therapist. Infect Control Hosp Epidemiol 2001; 22: 423426.
  • 320
    Mann T, Ben-David D, Zlotkin A et al. An outbreak of Burkholderia cenocepacia bacteremia in immunocompromised oncology patients. Infection 2010; 38: 187194.
  • 321
    Centers for Disease Control and Prevention (CDC). Nosocomial Burkholderia cepacia infection and colonization associated with intrinsically contaminated mouthwash – Arizona, 1998. MMWR Morb Mortal Wkly Rep 1998; 47: 926928.